BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26170293)

  • 1. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.
    McGlinchey RP; Lee JC
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9322-7. PubMed ID: 26170293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
    McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
    J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
    Cermak S; Kosicek M; Mladenovic-Djordjevic A; Smiljanic K; Kanazir S; Hecimovic S
    PLoS One; 2016; 11(11):e0167428. PubMed ID: 27902765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils.
    Tsujimura A; Taguchi K; Watanabe Y; Tatebe H; Tokuda T; Mizuno T; Tanaka M
    Neurobiol Dis; 2015 Jan; 73():244-53. PubMed ID: 25466281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taking a Bite Out of Amyloid: Mechanistic Insights into α-Synuclein Degradation by Cathepsin L.
    McGlinchey RP; Dominah GA; Lee JC
    Biochemistry; 2017 Aug; 56(30):3881-3884. PubMed ID: 28614652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin K is a potent disaggregase of α-synuclein fibrils.
    McGlinchey RP; Lacy SM; Walker RL; Lee JC
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1106-1111. PubMed ID: 32819572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin L prevents the accumulation of alpha-synuclein fibrils in the cell.
    Matsuki A; Watanabe Y; Hashimoto S; Hoshino A; Matoba S
    Genes Cells; 2024 Apr; 29(4):328-336. PubMed ID: 38366711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.
    Bellomo G; Paciotti S; Gatticchi L; Parnetti L
    Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells.
    Crabtree D; Dodson M; Ouyang X; Boyer-Guittaut M; Liang Q; Ballestas ME; Fineberg N; Zhang J
    J Neurochem; 2014 Mar; 128(6):950-61. PubMed ID: 24138030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.
    Tholen S; Biniossek ML; Gansz M; Ahrens TD; Schlimpert M; Kizhakkedathu JN; Reinheckel T; Schilling O
    Cell Mol Life Sci; 2014 Mar; 71(5):899-916. PubMed ID: 23811845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches.
    Drobny A; Prieto Huarcaya S; Dobert J; Kluge A; Bunk J; Schlothauer T; Zunke F
    Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119243. PubMed ID: 35217144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.
    Menzel K; Hausmann M; Obermeier F; Schreiter K; Dunger N; Bataille F; Falk W; Scholmerich J; Herfarth H; Rogler G
    Clin Exp Immunol; 2006 Oct; 146(1):169-80. PubMed ID: 16968411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis.
    Gallwitz L; Bleibaum F; Voss M; Schweizer M; Spengler K; Winter D; Zöphel F; Müller S; Lichtenthaler S; Damme M; Saftig P
    Cell Mol Life Sci; 2024 May; 81(1):227. PubMed ID: 38775843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
    Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
    Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species.
    Sevlever D; Jiang P; Yen SH
    Biochemistry; 2008 Sep; 47(36):9678-87. PubMed ID: 18702517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
    Qiao L; Hamamichi S; Caldwell KA; Caldwell GA; Yacoubian TA; Wilson S; Xie ZL; Speake LD; Parks R; Crabtree D; Liang Q; Crimmins S; Schneider L; Uchiyama Y; Iwatsubo T; Zhou Y; Peng L; Lu Y; Standaert DG; Walls KC; Shacka JJ; Roth KA; Zhang J
    Mol Brain; 2008 Nov; 1():17. PubMed ID: 19021916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.
    Ruz C; Barrero FJ; Pelegrina J; Bandrés-Ciga S; Vives F; Duran R
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential redox sensitivity of cathepsin B and L holds the key to autophagy-apoptosis interplay after Thioredoxin reductase inhibition in nutritionally stressed SH-SY5Y cells.
    Nagakannan P; Eftekharpour E
    Free Radic Biol Med; 2017 Jul; 108():819-831. PubMed ID: 28478025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.